Hays Advisory Position in Oracle (ORCL) Has Decreased by $513,168; Globeflex Capital LP Boosted Merit Med Sys (MMSI) Position by $302,400 as Market Valuation Rose

January 18, 2018 - By Darrin Black

Globeflex Capital LP increased its stake in Merit Med Sys Inc (MMSI) by 32.37% based on its latest 2017Q3 regulatory filing with the SEC. Globeflex Capital LP bought 7,200 shares as the company’s stock rose 18.76% with the market. The institutional investor held 29,442 shares of the health care company at the end of 2017Q3, valued at $1.25 million, up from 22,242 at the end of the previous reported quarter. Globeflex Capital LP who had been investing in Merit Med Sys Inc for a number of months, seems to be bullish on the $2.33B market cap company. The stock decreased 0.85% or $0.4 during the last trading session, reaching $46.4. About 277,649 shares traded. Merit Medical Systems, Inc. (NASDAQ:MMSI) has risen 81.84% since January 18, 2017 and is uptrending. It has outperformed by 65.14% the S&P500.

Hays Advisory Llc decreased its stake in Oracle Corp (ORCL) by 8.38% based on its latest 2017Q3 regulatory filing with the SEC. Hays Advisory Llc sold 10,691 shares as the company’s stock rose 5.35% with the market. The institutional investor held 116,849 shares of the prepackaged software company at the end of 2017Q3, valued at $5.65M, down from 127,540 at the end of the previous reported quarter. Hays Advisory Llc who had been investing in Oracle Corp for a number of months, seems to be less bullish one the $207.93B market cap company. The stock decreased 0.08% or $0.04 during the last trading session, reaching $50.23. About 13.70M shares traded. Oracle Corporation (NYSE:ORCL) has risen 14.08% since January 18, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

Investors sentiment decreased to 1.28 in Q3 2017. Its down 0.21, from 1.49 in 2017Q2. It worsened, as 14 investors sold MMSI shares while 71 reduced holdings. 44 funds opened positions while 65 raised stakes. 44.33 million shares or 0.69% more from 44.02 million shares in 2017Q2 were reported. Congress Asset Communication Ma holds 48,555 shares or 0.03% of its portfolio. Engineers Gate Manager Limited Partnership accumulated 15,138 shares or 0.05% of the stock. Oppenheimer Asset Management Inc invested 0.01% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Atria Invests Lc holds 7,531 shares or 0.02% of its portfolio. Bogle Invest Management Ltd Partnership De stated it has 0.02% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). State Board Of Administration Of Florida Retirement Systems holds 0% or 41,490 shares. Ig Inv Management Ltd stated it has 0.01% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). Louisiana State Employees Retirement holds 0.04% or 20,300 shares. Pnc Fincl Service Grp Inc Inc invested in 51,336 shares or 0% of the stock. Timpani Capital Management Ltd has invested 2.33% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Neuberger Berman Grp Inc Incorporated Ltd Liability Co has invested 0.02% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). Cubist Systematic Strategies Llc holds 0.03% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 11,026 shares. Ubs Asset Mngmt Americas invested 0% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). Deutsche Comml Bank Ag has invested 0% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). Wells Fargo Mn has invested 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI).

Globeflex Capital L P, which manages about $3.98 billion and $351.17M US Long portfolio, decreased its stake in Apollo Global Management Cl A Ord (NYSE:APO) by 41,011 shares to 25,851 shares, valued at $778,000 in 2017Q3, according to the filing. It also reduced its holding in Tcf Finl Corp (NYSE:TCB) by 37,534 shares in the quarter, leaving it with 53,458 shares, and cut its stake in Bunge Limited (NYSE:BG).

Among 8 analysts covering Merit Medical (NASDAQ:MMSI), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Merit Medical had 18 analyst reports since October 23, 2015 according to SRatingsIntel. The rating was maintained by Wells Fargo on Thursday, November 30 with “Buy”. Bank of America initiated Merit Medical Systems, Inc. (NASDAQ:MMSI) on Thursday, July 20 with “Buy” rating. The stock of Merit Medical Systems, Inc. (NASDAQ:MMSI) has “Buy” rating given on Thursday, November 16 by SunTrust. The stock has “Buy” rating by Canaccord Genuity on Thursday, July 27. On Monday, August 28 the stock rating was downgraded by Raymond James to “Outperform”. The rating was maintained by Canaccord Genuity on Sunday, October 8 with “Buy”. The stock of Merit Medical Systems, Inc. (NASDAQ:MMSI) earned “Mkt Perform” rating by Barrington Research on Friday, October 23. Canaccord Genuity maintained it with “Buy” rating and $50.0 target in Tuesday, January 2 report. Canaccord Genuity maintained it with “Buy” rating and $45.0 target in Monday, September 4 report. The rating was initiated by Canaccord Genuity on Tuesday, July 19 with “Buy”.

Since August 3, 2017, it had 0 buys, and 6 insider sales for $1.99 million activity. $1.03M worth of Merit Medical Systems, Inc. (NASDAQ:MMSI) shares were sold by ANDERSON A SCOTT. Millner F. Ann sold $127,389 worth of Merit Medical Systems, Inc. (NASDAQ:MMSI) on Thursday, August 3.

Analysts await Oracle Corporation (NYSE:ORCL) to report earnings on March, 21. They expect $0.66 EPS, up 4.76% or $0.03 from last year’s $0.63 per share. ORCL’s profit will be $2.73 billion for 19.03 P/E if the $0.66 EPS becomes a reality. After $0.62 actual EPS reported by Oracle Corporation for the previous quarter, Wall Street now forecasts 6.45% EPS growth.

Among 38 analysts covering Oracle (NYSE:ORCL), 28 have Buy rating, 0 Sell and 10 Hold. Therefore 74% are positive. Oracle had 103 analyst reports since July 30, 2015 according to SRatingsIntel. Citigroup maintained the shares of ORCL in report on Friday, June 17 with “Neutral” rating. The rating was maintained by RBC Capital Markets on Friday, December 16 with “Outperform”. Morgan Stanley maintained Oracle Corporation (NYSE:ORCL) rating on Friday, June 23. Morgan Stanley has “Equal Weight” rating and $47 target. The stock of Oracle Corporation (NYSE:ORCL) earned “Market Perform” rating by JMP Securities on Thursday, March 16. The firm has “Sector Weight” rating by Pacific Crest given on Monday, October 19. The rating was maintained by Stifel Nicolaus on Thursday, June 22 with “Buy”. RBC Capital Markets downgraded the stock to “Sector Perform” rating in Friday, December 15 report. The rating was upgraded by Goldman Sachs on Monday, November 16 to “Conviction Buy”. The rating was maintained by Goldman Sachs with “Buy” on Wednesday, March 16. The rating was initiated by BMO Capital Markets on Friday, January 8 with “Market Perform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts